Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

29,773 signal articles · 72 in last 24h · 148,348 total before filter · latest 1h ago
72last 24h
975last 7d
109● bullish (7d)
124● bearish (7d)
212publishers
AllMacro369Earnings115M&A98Regulatory8Product11Analyst11
✕ clear all filtersticker: UNHSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
3 Health Care Stocks Built For Higher Rates
Simply Wall St.2d agoneutral
3 Health Care Stocks Built For Higher Rates

When the Federal Reserve lifts rates and signals they may stay elevated for years, the easy-growth playbook breaks. Cash flows today matter more than promises tomorrow, and investors start to care a lot about balance sheet strength, pricing power and dependable dividends. This article walks through three large cap quality defensive stocks that screen well under those rules and explains how the latest Fed move could affect each one. The three stocks below are a sample of what this quality...

Mangione Admits to Killing Healthcare CEO Brian Thompson
Bloomberg35d agoneutralVIDEO
Mangione Admits to Killing Healthcare CEO Brian Thompson

Luigi Mangione pleaded guilty to federal stalking charges related to the fatal shooting of UnitedHealth Group Inc. executive Brian Thompson. Mangione admitted on Friday in New York federal court that he shot and killed Thompson on Dec. 4, 2024. He faces life in prison. Mangione's attorney, Karen Friedman Agnifilo, US Attorney for the Southern District Jamie McDonald and NYPD Police Commissioner Jessica Tisch all spoke outside the court.

Mangione Pleads Guilty in US Case Over Healthcare CEO Killing
Bloomberg36d agoneutralVIDEO
Mangione Pleads Guilty in US Case Over Healthcare CEO Killing

Luigi Mangione pleaded guilty to federal stalking charges related to the fatal shooting of UnitedHealth Group Inc. executive Brian Thompson. He faces a maximum sentence of life in prison. This happened in New York federal court Friday morning. Mangione also faces charges in New York state court. June Grasso of Bloomberg Law is following the breaking news on Bloomberg Radio and has more.

Medicare Drug Plan Premiums Are About to Jump for 25 Million Seniors
Barrons.com52d agobullish
Medicare Drug Plan Premiums Are About to Jump for 25 Million Seniors

Medicare beneficiaries may face higher premiums next year for their Part D drug plans, as the federal government plans to end subsidies that helped mitigate price increases in the program. The Trump administration will not continue the subsidies beyond 2026, The Wall Street Journal reported. About 25 million Medicare recipients are enrolled in a stand-alone Part D plan for their drug coverage.

Why Prices Could Rise for Medicare Drug Plans Next Year
Barrons.com52d agoneutral
Why Prices Could Rise for Medicare Drug Plans Next Year

Medicare beneficiaries may face higher premiums next year for their Part D drug plans, as the federal government plans to end subsidies that helped mitigate price increases in the program. The Trump administration will not continue the subsidies beyond 2026, The Wall Street Journal reported. About 25 million Medicare recipients are enrolled in a stand-alone Part D plan for their drug coverage.

Netflix Earnings, Consumer Sentiment: What to Watch the Rest of the Week
The Wall Street Journal65d agoneutral
Netflix Earnings, Consumer Sentiment: What to Watch the Rest of the Week

Today Earnings (a.m): UnitedHealth, GE Aerospace, U.S. Bancorp, Citizens Financial, Abbott Laboratories, State Street, Taiwan Semiconductor Manufacturing Earnings (p.m.): Netflix, Intuitive Surgical Economic data: Weekly jobless claims, Philadelphia Fed business-outlook survey, retail sales, pending home sales index, business inventories Fed speakers: Fed Vice Chair Philip Jefferson is expected to speak, as is Dallas Fed President Lorie Logan.

VTV’s Next 12 Months Hinge on One Fed Inflation Signal: Here’s What to Watch
24/7 Wall St.79d agoneutral
VTV’s Next 12 Months Hinge on One Fed Inflation Signal: Here’s What to Watch

The Vanguard Value ETF (NYSEARCA:VTV) has turned into one of the best large-cap stories of 2026, trading near $218 with a 16% year-to-date gain and a 27% advance over the past year. That run rests on a narrow set of legs: a healthcare snapback led by UnitedHealth, a financial-sector grind led by JPMorgan, and energy ... VTV’s Next 12 Months Hinge on One Fed Inflation Signal: Here’s What to Watch

UnitedHealth Group (UNH) Reaches Proposed FTC Settlement Over Insulin Rebating Practices
Simply Wall St.88d agoneutral
UnitedHealth Group (UNH) Reaches Proposed FTC Settlement Over Insulin Rebating Practices

UnitedHealth Group (NYSE:UNH) subsidiaries OptumRx and Emisar Pharma Services have reached a proposed settlement with the Federal Trade Commission over alleged anticompetitive insulin rebating practices. The FTC has paused further proceedings while it reviews the settlement terms related to insulin pricing and rebating conduct. The agreement focuses on resolving regulatory concerns tied to pharmacy benefit management activities in the insulin market. For investors watching UnitedHealth...

CVS Health (CVS) Under the Microscope After Recent Healthcare Report
Insider Monkey88d agoneutral
CVS Health (CVS) Under the Microscope After Recent Healthcare Report

CVS Health Corporation (NYSE:CVS) is one of the 10 Cheap Jim Cramer Stocks to Invest In Right Now. The New York Times, in an article published on June 11, 2026, pointed to two federal reports from the Department of Health and Human Services and stated that CVS Health Corporation (NYSE:CVS) and other major Medicare Advantage […]

UnitedHealth (UNH) Takes Major Step Toward Resolving FTC Insulin Pricing Dispute
Insider Monkey89d agoneutral
UnitedHealth (UNH) Takes Major Step Toward Resolving FTC Insulin Pricing Dispute

With a short percentage of shares outstanding of 2.12%, UnitedHealth Group Incorporated (NYSE:UNH) is among the 7 Best Longevity and Anti-Aging Stocks to Buy. On June 12, subsidiaries of UnitedHealth Group Incorporated (NYSE:UNH), including OptumRx and Emisar Pharma Services, reached an agreement with the Federal Trade Commission to settle allegations that the companies engaged in anticompetitive and unfair rebating […]